Health
Lilly Sells Zepbound Vials at 50% Discount to Meet Weight Loss Drug Demand
- Vials sold via LillyDirect cost either $399 or $549 a month
- Patient-led campaign asked drugmaker to #ReleaseTheVials
This article is for subscribers only.
Eli Lilly & Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome supply shortages of wildly popular shots.
Patients with a prescription for Zepbound can purchase a month’s supply of single-use vials through Lilly’s direct-to-consumer site starting Tuesday, the company said in a statement. The vials are priced at about half of what shots cost, with a higher dose going for $549 a month.